Home › FDA approves Bristol-Myers drug for new use in kidney cancer
 

Keywords :   


FDA approves Bristol-Myers drug for new use in kidney cancer

2015-11-24 01:49:24| Biotech - Topix.net

" Federal health regulators have expanded approval of a cancer drug from Bristol-Myers Squibb to treat an advanced form of kidney cancer. The Food and Drug Administration says the injectable-drug, Opdivo, is approved for patients with renal cell carcinoma who have previously tried certain other drugs.

Tags: drug cancer kidney fda

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
23.05Wood Coatings Market Expected to Reach $17.8B by 2033: AMR
23.05Demand strengthening pork, hog prices
23.05Xperi debuts TiVo One cross-screen ad platform
23.05Global TV shipments declined 4% YoY in Q1 2024
23.05Allen Media Group offers in-stream 'Frame' ads with BrightLine
23.05beIN MEDIA to launch targeted TV advertising with Synamedia
23.05Vets market faces probe into bill overpayment fears
23.05Eastern North Pacific Tropical Weather Outlook
More »